Eli Lilly and Company is seeking a postdoctoral scientist to advance precision therapies at the intersection of cellular senescence biology, fibrosis, and immune-based therapeutics. Your work will contribute to a high-visibility research program and open new therapeutic avenues in the senolytics space.
The role spans cellular models, in vivo fibrosis models, and human tissue, with opportunities to publish as first author and present at major conferences.
#J-18808-LjbffrPostdoc Immunology: Senolytics for Fibrotic Lung in san francisco at Unknown Company
This position is listed as full time and onsite.